Factor | Berge_2006_AppandEnvMic (10249)

10.1128/AEM.02239-05

Antimicrobial Use

Cattle | None

6

Description

Group 2 vs Group 4 (see Table 1 for therapeutic indications, milk replacer contains tetracycline hydrochloride (22 mg/kg body weight/day) and neomycin sulfate (22 mg/kg/day)). Both groups were housed on a calf ranch. Data is from Day 14.

Resistance Outcomes

Resistance Microbe Outcome
Cefalotin
/
Escherichia None
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 4 (antimicrobial therapy available and medicated milk replacer) 83 90
Group 2 (no antimicrobial therapy available, non-medicated milk replacer) 15 72
Ceftiofur
/
Escherichia None
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 4 (antimicrobial therapy available and medicated milk replacer) 83 90
Group 2 (no antimicrobial therapy available, non-medicated milk replacer) 14 72
Amikacin
/
Escherichia None
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 4 (antimicrobial therapy available and medicated milk replacer) 50 90
Group 2 (no antimicrobial therapy available, non-medicated milk replacer) 0 72
Gentamicin
/
Escherichia None
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 4 (antimicrobial therapy available and medicated milk replacer) 78 90
Group 2 (no antimicrobial therapy available, non-medicated milk replacer) 13 72
Streptomycin
/
Escherichia None
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 4 (antimicrobial therapy available and medicated milk replacer) 90 90
Group 2 (no antimicrobial therapy available, non-medicated milk replacer) 50 72
Sulfafurazole
/
Escherichia None
See: Table 3 (and Table 2) AMR+ (n) AMR- (n) Total (n)
Group 4 (antimicrobial therapy available and medicated milk replacer) 90 90
Group 2 (no antimicrobial therapy available, non-medicated milk replacer) 48 72